Trinity Innovation Fund
Beijing, Beijingtrinity-fund.com
Overview
Trinity Innovation Fund (TIF) is a venture capital firm founded in 2018 and based in Beijing, China. It specializes in early and growth-stage investments in the biomedical, biotechnology, drug discovery, and pharmaceutical industries. The firm operates with a philosophy described as the "Triad of scientists, managers and investors". TIF also has a Singapore-based entity, Trinity Innovation Bioventure Singapore (TIBS), which is part of the Trinity Innovation Fund group and focuses on the Asian market.
Portfolio Companies
8
Website
trinity-fund.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vibrant Therapeutics | Aug 2025 | Series A | Lead |
| Adcentrx Therapeutics | Dec 2023 | Series A Extension | Co-investor |
| Cholesgen Pharmaceutical | May 2023 | Series A | Co-investor |
| Adcentrx Therapeutics | Apr 2023 | Series A Extension | Co-investor |
| Epigenic Therapeutics | Aug 2022 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
